Next Article in Journal
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy
Next Article in Special Issue
Translational Models in Glioma Immunotherapy Research
Previous Article in Journal
A Descriptive Study of Repeated Hospitalizations and Survival of Patients with Metastatic Melanoma in the Northern Italian Region during 2004–2019
Previous Article in Special Issue
Pediatric Brain Tumours: Lessons from the Immune Microenvironment
 
 
Review

Article Versions Notes

Curr. Oncol. 2023, 30(6), 5279-5298; https://doi.org/10.3390/curroncol30060401
Action Date Notes Link
article xml file uploaded 25 May 2023 13:38 CEST Original file -
article xml uploaded. 25 May 2023 13:38 CEST Update https://www.mdpi.com/1718-7729/30/6/401/xml
article pdf uploaded. 25 May 2023 13:38 CEST Version of Record https://www.mdpi.com/1718-7729/30/6/401/pdf
article html file updated 25 May 2023 13:40 CEST Original file -
article html file updated 25 May 2023 13:41 CEST Update -
article html file updated 25 May 2023 13:41 CEST Update https://www.mdpi.com/1718-7729/30/6/401/html
Back to TopTop